Ranibizumab
Anti-VEGF eye injection for macular degeneration and diabetic eye disease.
- Starts working
- Weeks
- Half-life
- About 9 days (vitreous)
- In use since
- —
- Pregnancy
- Use with caution
Overview
Ranibizumab is injected into the eye to block VEGF. It treats wet age-related macular degeneration, diabetic macular oedema and retinal vein occlusion. Biosimilars are available.
Conditions it's used for
How it works
Stops abnormal blood vessels leaking in the retina.
Ranibizumab belongs to the Anti-VEGF injections. How Anti-VEGF injections work: block the signal that grows fragile, leaky blood vessels under the retina.
Uses
- Wet age-related macular degeneration
- Diabetic macular oedema
- Retinal vein occlusion
- Myopic choroidal neovascularisation
Available as: intravitreal injection.
Typical dose
- Adults
- 0.5 mg injected into the eye monthly, then as needed or at extended intervals.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Eye pain
- Floaters
- Redness
- Raised eye pressure
Serious — get medical help
Uncommon, but need prompt attention
- Endophthalmitis (serious eye infection)
- Retinal detachment
- Arterial clots (rare)
Warnings
- Report eye pain, vision loss or redness after injection immediately
Who should avoid it
- Active eye infection
- Active intraocular inflammation
Interactions
- Verteporfin — timing
Using it safely
- Alcohol
- Usually no problem in moderation. No specific interaction.
- Food and drink
- Not applicable.
- If you miss a dose
- Rebook the next injection.
- Stopping it
- Follow your retina specialist.
- Driving
- Do not drive until vision recovers after injection.
- Tests and checks
- Vision; Eye pressure
- If too much is taken
- Raised eye pressure; hospital review.
- Storage
- Refrigerate.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Use with caution
Limited data; specialist decision.
Breastfeeding
Use with caution
Limited data.
Special groups
- Kidney disease
- Not generally used.
- Liver disease
- No adjustment.
- Older adults
- Standard dosing.
Brand names
- United States
- Lucentis, Byooviz, Cimerli
- United Kingdom
- Lucentis, Ranivisio
- India
- Lucentis, Razumab, Ranibizumab biosimilars
- Australia
- Lucentis
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Ranibizumab?
Yes — Ranibizumab is prescription-only in most countries.
Can I take Ranibizumab during pregnancy?
Use with caution. Limited data; specialist decision. Always check with a doctor or midwife.
How quickly does Ranibizumab work?
Weeks.
Related medicines
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — S01LA04
- WHO Model List of Essential Medicines
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.